4-(1-Acetylpiperazin-4-yl)Phenol

We are 4-(1-Acetylpiperazin-4-yl)Phenol CAS:67914-60-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 4-(1-Acetylpiperazin-4-yl)Phenol
CAS.NO: 67914-60-7
Synonyms:
1-[4-(4-hydroxyphenyl)piperazin-1-yl]ethanone

Molecular Formula: C12H16N2O2
Molecular Weight:220.26800

Physical and Chemical Properties:
Density: 1.207 g / cm3
Boiling point: 456.5ºC at 760 mmHg
Melting point: 180-185 ° C (lit.)
Flash point: 229.9ºC
Refractive index: 1.584

Specification:
Appearance: White powder
Purity:≥98%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage: -20℃ Freezer.Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Ketoconazole CAS:65277-42-1

4-(1-Acetylpiperazin-4-yl)Phenol


Related News: The API is not made by only one reaction from the raw materials but rather it becomes an API via several chemical compounds.2-(4-chlorophenyl)-3-methylbutyric acid CAS:2012-74-0 In order to seize the highest point of profits, international industry giants have adjusted their development strategies, concentrated their energies on the two ends of the smile curve-research and development and end products, and shifted production links such as intermediates and APIs outward. A division of labor model has been formed.6092-54-2 Corden Pharma group companies offer contract development and contract manufacturing for advanced pharmaceutical intermediates, APIs, and drug product formulations with more than 1,500 individuals supporting their customers with specialized technologies in all international markets.4''-(Pentyloxy)-1,1':4',1''-terphenyl-4-carboxylic acid CAS:158938-08-0 Corden Pharma group companies offer contract development and contract manufacturing for advanced pharmaceutical intermediates, APIs, and drug product formulations with more than 1,500 individuals supporting their customers with specialized technologies in all international markets.“With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.”

Related Products
Product Name
N,N,N’,N’-Tetramethyl-1,3-propanediamine View Details
3-triethoxysilyl-N-(3-triethoxysilylpropyl)propan-1-amine View Details
4-methylsulfanylbenzaldehyde View Details
3-Amino-4-methoxybenzamide manufacturer Methyl isobutyryl acetate manufacturer 3-Methyl-3-Pyrazolin-5-One manufacturer (4-Chlorobutyl)Benzene manufacturer CAS:75980-60-8 Diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide manufacturer